Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

3-Quinuclidinol

3-Quinuclidinol is listed in the pharmaceutical impurity collection under CAS 1619-34-7. Its represented structure has formula C7H13NO and a calculated molecular weight of 127.19 g/mol.

2D chemical structure

H O N

Chemical identity

Catalog name
3-Quinuclidinol
Common name
3-Quinuclidinol
Chemical name
1-azabicyclo[2.2.2]octan-3-ol
CAS
1619-34-7
SMILES
OC1CN2CCC1CC2
InChI
InChI=1S/C7H13NO/c9-7-5-8-3-1-6(7)2-4-8/h6-7,9H,1-5H2
InChIKey
IVLICPVPXWEGCA-UHFFFAOYSA-N
Associated API
Quinuclidinyl Benzilate

Record ID: A40ca34216c29

Computed properties

C7H13NO Molecular formula
127.187 g/molMolecular weight
127.0997 DaMonoisotopic exact mass
23.47 ŲTopological polar surface area
0.0729 Calculated LogP (Wildman–Crippen)
35.1708 cm³/molMolar refractivity (Wildman–Crippen)
2 countHydrogen-bond acceptors
1 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD. 1 potential atom stereocenters have unspecified configuration.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 1 2 3 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C H N O 0 3 6 9 12 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight127.1872.76
Calculated LogP (Wildman–Crippen)0.072914.72
Topological polar surface area23.478.35
Hydrogen-bond acceptors215.92
Hydrogen-bond donors138.08
Rotatable bonds (strict)03.45

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC7H13NOdimensionless
Molecular weight127.187g/mol
Monoisotopic exact mass127.0997Da
Topological polar surface area23.47Ų
Calculated LogP (Wildman–Crippen)0.0729dimensionless
Molar refractivity (Wildman–Crippen)35.1708cm³/mol
Hydrogen-bond acceptors2count
Hydrogen-bond donors1count
Rotatable bonds (strict)0count
Heavy atoms9count
Heteroatoms2count
Rings3count
Aromatic rings0count
Aliphatic rings3count
Saturated rings3count
Aromatic heterocycles0count
Aliphatic heterocycles3count
Saturated heterocycles3count
Aromatic carbocycles0count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms1fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters1count
Unspecified atom stereocenters1count
Spiro atoms0count
Bridgehead atoms2count
Labute approximate surface area55.4713Ų
Valence electrons52count
Radical electrons0count
Bertz complexity107.4838index
Balaban J2.0628index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for 3-Quinuclidinol

Qualification and safety assessment of 3-Quinuclidinol

Explore toxicological qualification of 3-Quinuclidinol and ICH M7 mutagenic impurity assessment of 3-Quinuclidinol for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for 3-Quinuclidinol and acceptable intake and limit justification for 3-Quinuclidinol. The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for 3-Quinuclidinol

Explore Altox services and software through the Altox Pharma-Hub.